| Biology medical industry is characterized as high tech, high risk, high investment, high benefits and long cycle. At present, international biology medical industry has presented the tendency such as increasing industrial investment and new focused investment fields; drastic growth with high investment in R&D activities; new sorts of medications applied with mature biology technology had gone into market in large volume; comprehensive R&D capability had been strengthened due to the compacting cooperation in strategic alliances. Later started point and weak R&D basis like Medical industry in china mainland featured, we had lagged far behind those advanced countries such as, America and Japan with less self- owned patent innovative products. Among them, the separation of manufacture and research activity and weak capability of industrialize biology medical research results severely restricted the healthy development of domestic biology medication industry.The establishment of stable and high efficient industrialized strategy alliance was a practical way, by which we could increase the competence of domestic biology industry, shorten the distance with international competitors and participant world competition. The first step in forming strategic alliance is the choice of wonderful cooperators who owned strong tech capability and advanced management measurements. Through the particular analysis of the features that exist in research and manufacture activities in biology medication industry, considering the inside requirements for establishing high efficient and stable strategic alliance, an index system was designed for evaluating suitable cooperators, which also provided a systematic and reliable tool for evaluation cooperators for other industries.
|
PDF Full Text Request